SRI International:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SRI International - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7265
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It performs research and development activities in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economic development, education and learning, energy and green tech, security and defense, sensing, space and radar, security and defense, robotics among others. SRI’s biomedical sector offers basic research on disease mechanisms, biologic drug discovery and development, nonclinical contract services, laboratory experiments, computer simulations, testing, behavioral pharmacology and other programs. The organization caters to government, corporations, commercial businesses, start up companies, industry consortiums, private foundations and venture firms. It has operations across the US. SRI is headquartered in Menlo Park, California, the US.

SRI International – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SRI International, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SRI International, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SRI International, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SRI International, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SRI International, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SRI International, Medical Equipment, Deal Details 10
Partnerships 10
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 10
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 11
Equity Offering 12
Ancora Medical Technology Spin Out from SRI International 12
SRI International Spins Off Superflex 13
SRI International – Key Competitors 14
SRI International – Key Employees 15
SRI International – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Product News 19
Apr 16, 2018: AI-Guided Cancer Therapy Platform from SRI International Identifies Novel Molecular Targets for Aggressive Form of Breast Cancer 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
SRI International, Medical Equipment, Key Facts 2
SRI International, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SRI International, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SRI International, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SRI International, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SRI International, Deals By Market, 2012 to YTD 2018 8
SRI International, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 10
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 11
Ancora Medical Technology Spin Out from SRI International 12
SRI International Spins Off Superflex 13
SRI International, Key Competitors 14
SRI International, Key Employees 15
SRI International, Other Locations 17
SRI International, Subsidiaries 18

List of Figures
SRI International, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SRI International, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SRI International, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SRI International, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SRI International, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SRI International, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SRI International, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SRI International:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kingspan Group Plc:企業のM&A・事業提携・投資動向
    Kingspan Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kingspan Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • SPIE SA (SPIE):電力:M&Aディール及び事業提携情報
    Summary SPIE SA (SPIE) provides multi-technical services in the areas of energy and communications. The company designs, builds, operates and maintains energy efficient and environmental facilities. It provides various products and services for developing efficient buildings. Its service offerings i …
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務情報
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aptinyx Inc (APTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptinyx Inc. (Aptinyx), formerly Enarex Inc, is a clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of neurological disorders. The company’s proprietary chemistry platform helps develop a pipeline of small-molecule modulators of N-methyl-D …
  • Spindletop Oil & Gas Co (SPND):石油・ガス:M&Aディール及び事業提携情報
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Genomic Health Inc (GHDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • New Zealand Energy Corp (NZ):企業の財務・戦略的SWOT分析
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • LifeWatch AG (LIFE)-医療機器分野:企業M&A・提携分析
    Summary LifeWatch AG (LifeWatch) is a healthcare technology and solutions company. It provides monitoring services and develops, manufactures, and markets advanced telehealth systems for high-risk and chronically ill patients. The company’s major services include mobile cardiac telemetry service, st …
  • Foundation for Innovative New Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Grupo Televisa S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hog’s Breath Cafe (Australia) Pty Ltd:企業の戦略・SWOT・財務情報
    Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Shimadzu Corp (7701):医療機器:M&Aディール及び事業提携情報
    Summary Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company’s product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufactu …
  • STRATA Skin Sciences Inc (SSKN):医療機器:M&Aディール及び事業提携情報
    Summary STRATA Skin Sciences Inc (STRATA) is a seller of therapeutic and aesthetic dermatology products. Its product portfolio comprises XTRAC laser and VTRAC excimer lamp; the STRATAPEN MicroSystems; and Nordlys. XTRAC laser and VTRAC excimer lamp systems are utilized for the treatment of psoriasis …
  • CalAmp Corp. (CAMP):企業の財務・戦略的SWOT分析
    CalAmp Corp. (CAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Emmaus Life Sciences Inc (EMMA):企業の財務・戦略的SWOT分析
    Emmaus Life Sciences Inc (EMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆